GT Biopharma, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
GTBP on Nasdaq
Location
505 Montgomery Street, 10 Th Floor, San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10/12/2024

GT Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Manu Ohri CFO & Secretary $100K Aug 11, 2023
Gregory Berk Pres. of R&D, CMO $79.8K Jul 15, 2022
Bruce Wendel Director Jan 27, 2023
Rajesh Shrotriya Director Jan 27, 2023
Gavin Choy Acting Chief Financial Officer Dec 31, 2021
Alan Urban Chief Financial Officer Sep 4, 2025
Charles J. Casamento Director Sep 4, 2025
Hilary Kramer Director Sep 4, 2025
Andrew J. Ritter Director May 8, 2025
David C. Mun-Gavin Director Sep 4, 2025
Michael Martin Breen CEO and Director, Director Sep 4, 2025

Recent Insider Transactions by Companies or Individuals for GT Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.